Physician profile
Jackson B Taylor
NPI 1487821559
$1,246.79
in general payments reported to CMS, 2019-2025
9 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $524 · 2024: $294 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969 · Travel and Lodging: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.81 |
| Travel and Lodging | $277.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $518.98 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Mentor Worldwide LLC | $193.26 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $192.47 | 2023-2025 | |
| Aroa Biosurgery Incorporated | $119.93 | 2025 | |
| Urgo Medical North America, LLC | $115.01 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Organogenesis INC. | $34.62 | 2025 | Apligraf |
| Solventum Corporation | $29.76 | 2024 | Activ.A.C. |
| Smith+Nephew, INC. | $23.22 | 2023 | Pico 7, Renasys Go V2 Home |
| Integra Lifesciences Corporation | $19.54 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.